Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Beshore

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Organic Letters|April 2, 2002
Preparation of substituted piperazinones via tandem reductive amination-(N,N'-acyl transfer)-cyclizationDouglas C Beshore, Christopher J Dinsmore
Journal of the American Chemical Society|September 19, 2008
The lyconadins: enantioselective total syntheses of (+)-lyconadin A and (-)-lyconadin BDouglas C Beshore, Amos B Smith
Journal of the American Chemical Society|March 21, 2007
Total syntheses of (+)-lyconadin A and (-)-lyconadin BDouglas C Beshore, Amos B Smith
Current Topics in Medicinal Chemistry|September 2, 2014
SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)Scott D Kuduk, Douglas C Beshore
Expert Opinion on Therapeutic Patents|October 25, 2012
Novel M(1) allosteric ligands: a patent reviewScott D Kuduk, Douglas C Beshore
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry|July 17, 2010
Construction of 5,6-Ring Fused 2-Pyridones: An Effective Annulation Tactic Achieved in WaterAmos B Smith, Onur Atasoylu, Douglas C Beshore
Journal of Medicinal Chemistry|February 22, 2022
Building a Culture of Medicinal Chemistry Knowledge SharingDouglas C Beshore, Andrew M Haidle, Ashok Arasappan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2007
Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failureChristopher P Regan, Laszlo Kiss, Gary L Stump, et al.
The Journal of Infection|October 25, 2024
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsMichael P Citron, Xiaowei Zang, Andrew Leithead, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Organic Letters|April 2, 2002
Preparation of substituted piperazinones via tandem reductive amination-(N,N'-acyl transfer)-cyclizationDouglas C Beshore, Christopher J Dinsmore
Journal of the American Chemical Society|September 19, 2008
The lyconadins: enantioselective total syntheses of (+)-lyconadin A and (-)-lyconadin BDouglas C Beshore, Amos B Smith
Journal of the American Chemical Society|March 21, 2007
Total syntheses of (+)-lyconadin A and (-)-lyconadin BDouglas C Beshore, Amos B Smith
Current Topics in Medicinal Chemistry|September 2, 2014
SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)Scott D Kuduk, Douglas C Beshore
Expert Opinion on Therapeutic Patents|October 25, 2012
Novel M(1) allosteric ligands: a patent reviewScott D Kuduk, Douglas C Beshore
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry|July 17, 2010
Construction of 5,6-Ring Fused 2-Pyridones: An Effective Annulation Tactic Achieved in WaterAmos B Smith, Onur Atasoylu, Douglas C Beshore
Journal of Medicinal Chemistry|February 22, 2022
Building a Culture of Medicinal Chemistry Knowledge SharingDouglas C Beshore, Andrew M Haidle, Ashok Arasappan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2007
Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failureChristopher P Regan, Laszlo Kiss, Gary L Stump, et al.
The Journal of Infection|October 25, 2024
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsMichael P Citron, Xiaowei Zang, Andrew Leithead, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 2018
Preclinical to Human Translational Pharmacology of the Novel M<sub>1</sub> Positive Allosteric Modulator MK-7622Jason M Uslaner, Scott D Kuduk, Marion Wittmann, et al.
Pageof 3